Vascular Calcification Is Associated with Impaired Microcirculatory Function in Chronic Haemodialysis Patients
- 28 January 2008
- journal article
- Published by S. Karger AG in Nephron Clinical Practice
- Vol. 108 (2), c121-c126
- https://doi.org/10.1159/000114202
Abstract
Although vascular calcification (VC) in dialysis patients is associated with increased cardiovascular events, the pathophysiology is still largely obscure. Microcirculatory dysfunction may contribute to demand myocardial ischaemia. We have studied cutaneous microcirculatory function in haemodialysis (HD) patients with and without large-vessel VC. 37 non-diabetic subjects (20 HD and 17 healthy controls) were studied. VC was assessed using CT scanning of a standardised segment of superficial femoral artery (11 VC+, 9 VC-). Laser Doppler imaging was undertaken using a Periscan PIM II(R) at rest and under vasodilator challenge. Baseline perfusion was not statistically different in VC+ patients than VC- patients or controls (1.03 +/- 0.2, 1.08 +/- 0.2, 0.93 +/- 0.3 PU respectively). Overall, the maximum vasodilatory response to both ACh (p < 0.001) and SNP (p = 0.004) was lower in the HD than the control group. In addition, the HD patients took longer to reach a maximum vasodilatation than the controls (p = 0.008 for ACh, n.s. for SNP). Further, the maximum vasodilatory response in the VC+ patients was lower and patients took longer to reach maximum vasodilatation than the VC- group. We have demonstrated, for the first time, impaired and dysregulated microcirculatory function in patients with VC. This may be important in understanding the pathophysiology of the complications and cardiovascular consequences of VC.This publication has 26 references indexed in Scilit:
- Laser Doppler flowmetry detection of endothelial dysfunction in end-stage renal disease patients: Correlation with cardiovascular riskKidney International, 2006
- Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysisKidney International, 2005
- Arterial Calcifications, Arterial Stiffness, and Cardiovascular Risk in End-Stage Renal DiseaseHypertension, 2001
- Primary Cutaneous Microangiopathy in Heart RecipientsMicrovascular Research, 2001
- Risk factors and mortality associated with calciphylaxis in end-stage renal diseaseKidney International, 2001
- Calciphylaxis is associated with hyperphosphatemia and increased osteopontin expression by vascular smooth muscle cellsAmerican Journal of Kidney Diseases, 2001
- Coronary-Artery Calcification in Young Adults with End-Stage Renal Disease Who Are Undergoing DialysisThe New England Journal of Medicine, 2000
- Postischemic vasodilation, endothelial activation, and cardiovascular remodeling in end-stage renal diseaseKidney International, 2000
- Clinical Subtypes of Alzheimer’s DiseaseDementia and Geriatric Cognitive Disorders, 1998
- Impaired Forearm Vasodilator Reserve in Patients with Microvascular AnginaThe New England Journal of Medicine, 1987